$G

Genpact (NYSE: G) insider plans $368K stock sale

Genpact (G) insider Balkrishan Kalra plans to sell 10,000 shares, valued at $367,904, on 9/14/26 via Morgan Stanley. The sale is under Rule 144, which governs insider stock transactions. This may impact share supply and price.

Original reporting
Published Sep 14, 2026, 8:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 8:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$G
Neutral
medium confidence
Mentioned
$G
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$GNeutralLow
01

Why it matters

The disclosed sale adds a modest amount of shares to the market, unlikely to move the price significantly.

02

Market read

Routine insider sale; low immediate trading relevance.

03

What to watch

Potential cumulative effect if other insiders also sell around the same time.

Relevance 4/10Novelty 4/10Timing: sale scheduled for today

Background

Genpact (NYSE:G) is a business process management firm. Rule 144 filings disclose planned sales of restricted shares.

Company-level read

Ticker impact

$GNeutralMedium confidence
Context

Insider Balkrishan Kalra filed a Rule 144 notice to sell 10,000 Genpact shares (~$368K) on Sep 14, 2026.

Expected impact

Minor downward pressure if the sale is executed quickly.

Evidence & confidence

The sale size is small relative to market cap; impact limited unless multiple insiders sell concurrently.

Market effects

No broader sector impact; insider sale is company‑specific.

Limited to US investors tracking Genpact.

Minimal global relevance.

Counterpoint

If insiders are selling, it could signal concerns, but the amount is too small to be material.

Key entities

  • Balkrishan Kalra

    Genpact employee filing the Rule 144 notice.

  • Morgan Stanley Smith Barney LLC

    Broker handling the planned sale.

Related articles

$GMed

Genpact’s ED NOC Rejection Quashed: Karnataka HC Remands Matter for Fresh Decision on USD 100 Million GIFT City Investment

The Karnataka High Court overturned the Enforcement Directorate's rejection of Genpact's application for a No-Objection Certificate (NOC) for a $100 million investment in GIFT City, stating that ongoing investigations alone do not justify refusal. The court also vacated interim protection against the ED's seizure of Genpact's Gurgaon property. The case involves a 2015 restructuring of Genpact's Indian operations and alleged FEMA violations.

MedAI 8/10

Karnataka High Court upholds ED seizure order against Genpact

The Karnataka High Court upheld an Enforcement Directorate (ED) seizure order against Genpact India under FEMA, while quashing the ED's refusal to grant a no-objection certificate (NOC) for $100 million overseas remittance. The court found the refusal lacked adequate reasons and ordered a fresh decision within 10 days. The ED had accused Genpact of siphoning foreign exchange, but the court did not rule on the merits of the case.

$GMedAI 8/10

Karnataka HC upholds Genpact office seizure in ₹7,800-cr case

The Karnataka High Court upheld the seizure of Genpact India's Gurugram office by the Enforcement Directorate in a ₹7,800-crore money-routing case. The court also directed authorities to reconsider Genpact's $100-million investment proposal in GIFT City. The case involves transactions with Morgan Stanley and Genpact entities.

$GMed

Genpact Q2 Earnings Call Highlights

Genpact (NYSE:G) said it expects more than $1 billion in agentic total contract value in 2026, about 5x 2025. Management reported 3% net revenue growth and 300 bps gross-margin expansion from clients shifting to agentic delivery. Q2 gross margin rose to 36.5%, adjusted operating income was $234M, and adjusted EPS was $1.00. Genpact reaffirmed 2026 revenue growth of at least 7% and guided Q3 revenue to $1.369B-$1.382B.